Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Sell
27
ENTX Quote, Financials, Valuation and Earnings
Last price:
$1.76
Seasonality move
:
-18.52%
Day range:
$1.75 - $1.94
52-week range:
$1.50 - $3.22
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
625.02x
P/B ratio:
5.30x
Volume:
375.6K
Avg. volume:
91K
1-year change:
-10.48%
Market cap:
$80.7M
Revenue:
$181K
EPS (TTM):
-$0.24
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Entera Bio Ltd. has 468.18% upside to fair value with a price target of $10.00 per share.
ENTX vs. S&P 500
-
Over the past 5 trading days, Entera Bio Ltd. has underperformed the S&P 500 by -17.44% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Entera Bio Ltd. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Entera Bio Ltd. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Entera Bio Ltd. reported revenues of --.
Earnings Growth
-
Entera Bio Ltd. has grown year-over-year earnings for 2 quarters straight. In the most recent quarter Entera Bio Ltd. reported earnings per share of -$0.07.
Enterprise value:
64.3M
EV / Invested capital:
4.16x
Price / LTM sales:
625.02x
EV / EBIT:
--
EV / Revenue:
518.69x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-8.73x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$15K
Return On Assets:
-71.11%
Net Income Margin (TTM):
-8694.36%
Return On Equity:
-81.18%
Return On Invested Capital:
-79.72%
Operating Margin:
-6102.38%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $14K | $99K | $124K | $42K | -- | |
| Gross Profit | -$53K | -$17K | -$15K | -- | -$8K | |
| Operating Income | -$10.1M | -$9.2M | -$10.8M | -$3M | -$3.3M | |
| EBITDA | -$10M | -$9.2M | -$10.8M | -$3M | -$3.2M | |
| Diluted EPS | -$0.34 | -$0.26 | -$0.24 | -$0.08 | -$0.07 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $28.1M | $15.2M | $8M | $7.3M | $17M | |
| Total Assets | $29.1M | $15.5M | $8.6M | $7.7M | $17.4M | |
| Current Liabilities | $2.9M | $1.2M | $2M | $1.1M | $1.6M | |
| Total Liabilities | $3.1M | $1.2M | $2.3M | $1.3M | $2.2M | |
| Total Equity | $26M | $14.3M | $6.2M | $6.5M | $15.2M | |
| Total Debt | $332K | $3K | $271K | $147K | $41K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$6.4M | -$7.8M | -$7.3M | -$2.2M | -$2.7M | |
| Cash From Investing | -$13.8K | -$4.8K | -$86.7K | -- | -$46.5K | |
| Cash From Financing | $4.8K | $7.1M | $17.4M | $18.3K | $803.7K | |
| Free Cash Flow | -$6.4M | -$7.8M | -$7.4M | -$2.2M | -$2.8M | |
ENTX
Sector
Market Cap
$80.7M
$28.4M
Price % of 52-Week High
54.66%
51.17%
Dividend Yield
0%
0%
Shareholder Yield
-19.79%
-1.49%
1-Year Price Total Return
-12%
-16.67%
Beta (5-Year)
1.706
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$2.01
200-day SMA
Sell
Level
$2.07
Bollinger Bands (100)
Sell
Level
1.82 - 2.56
Chaikin Money Flow
Sell
Level
-1.1M
20-day SMA
Sell
Level
$2.14
Relative Strength Index (RSI14)
Sell
Level
34.51
ADX Line
Sell
Level
27.61
Williams %R
Buy
Level
-87.931
50-day SMA
Sell
Level
$2.45
MACD (12, 26)
Sell
Level
-0.14
25-day Aroon Oscillator
Sell
Level
-88
On Balance Volume
Sell
Level
-512.3K
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (18.3717)
Sell
CA Score
(Annual)
Level (-2.8322)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
Sell
Ohlson Score
Level (14.5581)
Buy
Piotroski F Score
(Annual)
Level (4)
Sell
Quality Ratio Score
Level (2)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.
Stock Forecast FAQ
In the current month, ENTX has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ENTX average analyst price target in the past 3 months is $10.00.
-
Where Will Entera Bio Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Entera Bio Ltd. share price will rise to $10.00 per share over the next 12 months.
-
What Do Analysts Say About Entera Bio Ltd.?
Analysts are divided on their view about Entera Bio Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Entera Bio Ltd. is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is Entera Bio Ltd.'s Price Target?
The price target for Entera Bio Ltd. over the next 1-year time period is forecast to be $10.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ENTX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Entera Bio Ltd. is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ENTX?
You can purchase shares of Entera Bio Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Entera Bio Ltd. shares.
-
What Is The Entera Bio Ltd. Share Price Today?
Entera Bio Ltd. was last trading at $1.76 per share. This represents the most recent stock quote for Entera Bio Ltd.. Yesterday, Entera Bio Ltd. closed at $1.88 per share.
-
How To Buy Entera Bio Ltd. Stock Online?
In order to purchase Entera Bio Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get ENTX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
ENTX
Sector
P/E ratio
--
23.89x
PEG ratio
--
-0.01x
P/B ratio
5.30x
1.81x
Price / LTM sales
625.02x
1.58x
Growth Metrics
ENTX
Sector
Revenue growth
-100%
4.62%
Earnings growth
15.21%
10.7%
Revenue (5-year growth)
-5.17%
6.5%
Earnings forecast
--
-$0.21
Profitability
ENTX
Sector
Profitability FY 2024
$9K
$3.6M
Return on invested capital
-79.72%
-31.84%
Return on assets
-71.11%
-27.96%
Return on equity
-81.18%
-37.63%
Earnings Date
Last Earnings Date
Nov
9
Next Earnings Date
Dec
24
Estimated Next Earnings Date
Mar
25
Balance Sheet
ENTX
Sector
Total cash
$16.6M
$26.4M
Short term investments
--
$25.7M
Total assets
$9.4M
$76.9M
Long term debt
$41K
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Is Bloom Energy The Best Stock to Buy Now?
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 23
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Buy
60
ZBIO alert for Dec 24
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
Buy
54
UNF alert for Dec 24
UniFirst Corp. [UNF] is up 0.77% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
